Results 61 to 70 of about 3,331 (189)
International Journal of Gynecology &Obstetrics, Volume 174, Issue 1, Page 299-308, July 2026.Abstract Objective Combined oral contraceptives (COCs) for dysmenorrhea management have been covered by the Japanese universal health insurance system since 2008. Several public awareness events regarding COC prescriptions for dysmenorrhea were implemented between 2013 and 2015, including media reports on COC‐related fatalities in 2013, drug safety ...
Risa Ishida +8 more
wiley +1 more source
Open Access Journal of Contraception, 2015 Joachim Marr,1 Zirong Huang,2 Baoxi Wang,3 Hongyan Zhang,4 Katrin Roth1 1Bayer Pharma AG, Berlin, Germany; 2Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 3Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing ...
Marr J, Huang Z, Wang B, Zhang H, Roth K
doaj
The menopause – a new chapter giving women a lust for life
Медицинский совет, 2019 Many women equate the word menopause primarily with decline of life. On the one hand, the aesthetic component of the delicate age makes negative contributions to the dissatisfaction with this state; on the other hand, the growing pool of somatic health ...
O. V. Yakushevskaya
doaj +1 more source
Estetrol‐based combined oral contraceptives: A systematic review of clinical outcomes
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 983-998, June 2026.This systematic review summarizes clinical outcomes of estetrol‐containing combined oral contraceptives, showing reliable contraceptive efficacy, predictable bleeding patterns, improved well‐being, and a favorable hemostatic and metabolic profile, suggesting a promising and potentially safer alternative to ethinylestradiol‐based formulations.
Mathilde Råberg +3 more
wiley +1 more source
Menopause: up the stairs leading down
Медицинский совет, 2020 Postmenopause is an important stage in physiological aging of women, which is associated with a whole complex of vegetative-vascular, mental, and metabolic-endocrine disorders that develop against the background of the ovarian failure and general age ...
S. A. Gasparyan +3 more
doaj +1 more source
Cardiovascular Health in Women—Across the Lifespan
Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
To estimate the comparative risk of venous thromboembolism (VTE) among patients initiating two different progestin-only pills (POPs), drospirenone versus ...
Arielle Langer +3 more
core +6 more sources
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 805-818, May 2026.Hormonal treatments for endometriosis (combined oral contraceptives/progestin‐only pills) do not show increased psychological or sexual risks compared with placebo. When pain is effectively controlled, these therapies appear well tolerated and may improve overall well‐being.
Noemi Salmeri +5 more
wiley +1 more source
Drospirenone-containing contraception: curative and preventive aspects of use [PDF]
Гинекология, 2015 The use of combined hormonal contraceptives is a pathogenetically sound method of treating pathological conditions associated with the menstrual cycle.
A V Ledina, V N Prilepskaya
doaj
Gynecol Obstet InvestObjectives: Endometrial preparation provides significant surgical benefits prior to hysteroscopic procedures. However, there is still no consensus on the optimal presurgical protocol.
Etrusco A +11 more
europepmc +2 more sources